Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2009 3
2010 3
2011 3
2012 5
2013 11
2014 5
2015 7
2016 3
2017 5
2018 5
2019 5
2020 4
2021 8
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.
Taïeb D, Hicks RJ, Hindié E, Guillet BA, Avram A, Ghedini P, Timmers HJ, Scott AT, Elojeimy S, Rubello D, Virgolini IJ, Fanti S, Balogova S, Pandit-Taskar N, Pacak K. Taïeb D, et al. Among authors: virgolini ij. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2112-2137. doi: 10.1007/s00259-019-04398-1. Epub 2019 Jun 29. Eur J Nucl Med Mol Imaging. 2019. PMID: 31254038 Free PMC article.
Treatment of high-grade glioma with radiolabeled peptides.
Waitz D, Putzer D, Kostron H, Virgolini IJ. Waitz D, et al. Among authors: virgolini ij. Methods. 2011 Nov;55(3):223-9. doi: 10.1016/j.ymeth.2011.09.004. Epub 2011 Sep 16. Methods. 2011. PMID: 21945580 Review.
Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy.
Mair C, Warwitz B, Fink K, Scarpa L, Nilica B, Maffey-Steffan J, Buxbaum S, Virgolini IJ. Mair C, et al. Among authors: virgolini ij. Ann Nucl Med. 2018 Aug;32(7):499-502. doi: 10.1007/s12149-018-1264-x. Epub 2018 May 23. Ann Nucl Med. 2018. PMID: 29797003
Repeated treatment with low dose of [131I]MIBG with good response and without toxicity.
Rossetti LM, Kroiss AS, Uprimny C, Buxbaum S, Virgolini IJ. Rossetti LM, et al. Among authors: virgolini ij. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Apr 23:S2253-654X(20)30140-2. doi: 10.1016/j.remn.2020.08.003. Online ahead of print. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021. PMID: 33903086 English, Spanish. No abstract available.
Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the 68Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer.
von Guggenberg E, Uprimny C, Klinger M, Warwitz B, Sviridenko A, Bayerschmidt S, di Santo G, Virgolini IJ. von Guggenberg E, et al. Among authors: virgolini ij. J Nucl Med. 2023 Jun;64(6):859-862. doi: 10.2967/jnumed.122.264977. Epub 2023 Jan 19. J Nucl Med. 2023. PMID: 36657979 Free article.
Nephrotoxicity and hematotoxicity one year after four cycles of peptide receptor radionuclide therapy (PRRT) and its impact on future treatment planning - A retrospective analysis.
Nilica B, Svirydenka A, Fritz J, Bayerschmidt S, Kroiss A, Gruber L, Virgolini IJ. Nilica B, et al. Among authors: virgolini ij. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 May-Jun;41(3):138-145. doi: 10.1016/j.remnie.2021.04.007. Epub 2021 Apr 15. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022. PMID: 35577489
60 results